Oxford Immunotec is a global, high-growth diagnostics company focused on developing and commercializing proprietary assays for immunology and infectious disease. The Company's T-SPOT.TB test has been approved for sale in over 50 countries, including the United States, where it has received pre-market approval from the Food and Drug Administration, Europe, where it has obtained a CE mark, as well as Japan and China. The Company is headquartered near Oxford, U.K. and in Marlborough, MA. http://www.oxfordimmunotec.com/north-america/wp-content/uploads/sites/2/Disclaimer-V2.pdf
Location: United Kingdom, England, Abingdon
Employees: 201-500
Total raised: $54M
Founded date: 2001
Investors 2
| Date | Name | Website |
| - | Wellington... | wellington... |
| - | New Leaf V... | nlvpartner... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 18.06.2012 | - | $28M | - |
| 30.04.2010 | Series D | $26M | - |
Mentions in press and media 8
| Date | Title | Description |
| 08.01.2021 | PerkinElmer to Acquire Oxford Immunotec Global PLC | PerkinElmer and Oxford Immunotec Global PLC are pleased to announce they have reached an agreement on terms under which PerkinElmer will acquire Oxford Immunotec. |
| 14.05.2015 | $475M fund will help commercialize Oxford University’s spinout tech firms | The University of Oxford has produced some of Britain’s greatest minds, and to help in its quest to stay at the forefront of technological innovation, the institution’s commercial arm has set up a £300 million ($475 million) fund to develop... |
| 14.05.2015 | $475M fund will help commercialize Oxford University’s spinout tech firms | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today! The University of Oxford has produced some of Bri... |
| 18.06.2012 | Oxford Immunotec Receives $28M | OXFORD, ENGLAND, Medical diagnostic company developing tests in the fields of infectious and immunological disease, announced today that it has raised a total of $28M in a new equity financing. >> Click here for more funding data o... |
| 18.06.2012 | Oxford Immunotec Raises $28M in Equity Financing | Oxford Immunotec, a Oxford, UK-based medical diagnostic company developing tests in the fields of infectious and immunological disease, has raised $28m in equity financing. The round was led by new investors Imperial Innovations and Invesco... |
| 30.04.2010 | Oxford Immunotec Closes Second Tranche of $26M Series D Financing | Oxford Immunotec Ltd., an Oxford, UK-based manufacturer and marketer of T cell-based diagnostic tests, closed the second tranche of a $26m Series D financing. The financing was led by NLV Partners, with additional participation from new inv... |
| 29.10.2007 | Life sciences briefing: Monday, Oct. 29, 2007 | Featured companies: Azaya Therapeutics, Global Care Solutions, Oxford Immunotec, RealSelf.com, Sequoia Pharmaceuticals, Tactile Systems Technology, WellGen, Zeltiq Aesthetics UPDATED: Expanded items on Oxford Immunotec, Zeltiq, Tactile Syst... |
| 14.07.2006 | Cambridge firm wins UK Bio Entrepreneur of the Year Award | Cambridge firm wins UK Bio Entrepreneur of the Year Award 14-07-2006 A Cambridge company was named as one of the UK's best new biotech innovators at the Bio Entrepreneur of the Year Awards hosted by UK Trade & Investment and London Firs... |